Abstract: A method for establishing a wireless connection based on a touch screen of a wireless device. The wireless device includes a slide-out processing section for determining, in response to a slide-out from an edge of the touch screen, a first slide-out parameter for determining by the other wireless device an object to be connected, and broadcasting the first slide-out parameter. The wireless device further includes a slide-in processing section for determining a slide-in parameter in response to a slide-in from the edge of the touch screen and reception of a second slide-out parameter directionally transmitted from the other wireless device. Furthermore, if the determined slide-in parameter matches the second slide-out parameter, then the slide-in processing section establishes a wireless connection between the wireless device and the other wireless device. As a result, an authenticated wireless connection between short-range wireless terminals can be established more conveniently.

Abstract: Devices, methods, and program products for determining an atmospheric pressure are disclosed. One electronic device includes a fan that dissipates heat. The fan rotates at a rotation speed. The electronic device also includes a heat source. The electronic device includes a calculation unit that determines an atmospheric pressure at a location of the electronic device. The electronic device also includes a first temperature sensor that senses an ambient temperature and sends first information corresponding to the ambient temperature to the calculation unit. The electronic device includes a second temperature sensor that senses a temperature of the heat source and sends second information corresponding to the temperature of the heat source to the calculation unit. The calculation unit determines the atmospheric pressure based on the first information, the second information, and the rotation speed of the fan.

Abstract: A thermo-magnetic cooling system and an electronic apparatus including the thermo-magnetic cooling system are described. The thermo-magnetic cooling system includes a heat source and a liquid cooling device. Heat emitted from the heat source is transferred to the liquid cooling device and fluid circulates in the liquid cooling device to dissipate heat. The fluid is a magnetic fluid that can be magnetized and demagnetized. A part of the liquid cooling device is provided with an external magnetic field so as to magnetize the magnetic fluid.

Abstract: A variation testing system environment for performing variation testing of web pages and applications is disclosed. Users requesting a view from a content provider are not randomly assigned to one of a plurality of variations of the view. Rather, a function is applied to each user's identifier in order to determine which variation of the view is provided to a client device of the user.

Abstract: An information interaction method, apparatus and system are provided. A sensitive operation pre-performing message is received from a terminal where a secondary account is located. The sensitive operation pre-performing message may carry a secondary account identifier. Based on the secondary account identifier and a pre-stored association relationship between a primary account identifier and the secondary account identifier, the primary account identifier corresponding to the secondary account identifier may be determined. Based on the determined primary account identifier, a sensitive operation verification request message may be sent to a terminal where the primary account is located. A verification result information may be received from the terminal where the primary account is located.

Abstract: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110? activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lympho

Abstract: The present disclosure discloses a sensitive operation verification method, apparatus, and system, and belongs to the field of network security. The method includes: acquiring encrypted verification information on an operating terminal; decrypting the encrypted verification information according to decryption information corresponding to a user account to obtain verification information; receiving a result of verification that is performed on the sensitive operation by a user according to the verification information; encrypting the verification result according to encryption information corresponding to the user account to obtain an encrypted verification result; and providing the encrypted verification result to the operating terminal, so that the operating terminal feeds back the encrypted verification result to the server, and after the server detects that the encrypted verification result is that the verification succeeds, the server authorizes the operating terminal to execute the sensitive operation.

Abstract: Disclosed are a service locking method, apparatuses and systems thereof. The method includes: receiving a locking request including identification information of a designated service and an identifier of an operating terminal, the designated service being a service of performing a sensitive operation to network virtual property; and sending an authentication request containing the identification information of the designated service and the identifier of the operating terminal to an authentication server, and locking the designated service upon receiving successful authentication information from the authentication server.

Abstract: A co-verification method, a two-dimensional code generation method, and a device and system therefor are provided. The method includes: performing first-type verification and second-type verification with a verification server, the first-type verification including at least one of user information verification, dynamic verification code verification, network shield verification, and token verification, and the second-type verification including two-dimensional verification; and receiving feedback information from the verification server, the feedback information being information sent by the verification server when the first-type verification and the second-type verification are both successful.

Abstract: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110? activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lympho

Abstract: Substituted bicyclic heteroaryls having the following formula where the variables are as defined herein, and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110? activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-pro

Abstract: A method for implementing a view mode switch of a graphical user interface (GUI) is provided. The method is performed at an electronic device with a touch screen display. In this method, a double-finger pinch gesture on a first sub-view object among a plurality of sub-view objects is detected, upon detection of the double-finger pinch gesture on the first sub-view object, the GUI performs a thumbnail-to-complete or complete-to-thumbnail view mode switch; an information content, which is associated with a sub-view object to be presented and adapted to the switched view mode of the GUI is acquired; and the sub-view object with the acquired information content is presented in the GUI.

Abstract: A method for implementing a view mode switch of a graphical user interface (GUI) is disclosed. The method is performed at an electronic device with a touch screen display. In this method, a single-finger double-tap gesture on a first sub-view object among a plurality of sub-view objects is detected, upon detection of the single-finger double-tap gesture on the first sub-view object, the GUI performs a thumbnail-to-complete or complete-to-thumbnail view mode switch; an information content, which is associated with a sub-view object to be presented and adapted to the switched view mode of the GUI is acquired; and the sub-view object with the acquired information content is presented in the GUI.

Abstract: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110 activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphob

Abstract: A system and computer program product for establishing a wireless connection based on a touch screen of a wireless device. The wireless device includes a slide-out processing section for determining, in response to a slide-out from an edge of the touch screen, a first slide-out parameter for determining by the other wireless device an object to be connected, and broadcasting the first slide-out parameter. The wireless device further includes a slide-in processing section for determining a slide-in parameter in response to a slide-in from the edge of the touch screen and reception of a second slide-out parameter directionally transmitted from the other wireless device. Furthermore, if the determined slide-in parameter matches the second slide-out parameter, then the slide-in processing section establishes a wireless connection between the wireless device and the other wireless device. As a result, an authenticated wireless connection between short-range wireless terminals can be established more conveniently.

Abstract: Described is a process for preparing docetaxel 1, including the following steps: a) hydroxyl acylation reaction of compound 2 and 3 to obtain compound 4; b) deprotection group R1 of the hydroxyl group of compound 4 obtained from step a to prepare compound 5; c) removing one tert-butoxycarbonyl of compound 5 obtained from step b to prepare compound 6; d) removing one acetyl of compound 6 obtained from step c to prepare compound 1; wherein, R1 represents tert-butyl dimethyl silyl, triethylsilyl, ethoxyethyl, tetrahydropyranyl, trichloroethoxycarbonyl or methoxymethyl, Boc is tert-butoxycarbonyl, Ac is acetyl, and Ph is phenyl. Also disclosed are intermediates of docetaxel and methods for preparation thereof.

Abstract: Benzamide derivatives of formulae I and II, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof, and pharmaceutical compositions comprising the same, are described and have therapeutic utility, particularly in the treatment of diabetes, obesity, and related conditions and disorders: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, and R12 are defined as provided herein.

Abstract: In the present invention, a synthesis method of Imatinib is disclosed, which comprises the following steps: the Imatinib, namely 4-(4-methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-[4-(3-pyridinyl)-pyrimidin-2-ylamino]-benzami de shown in formula (III), is formed by reacting 4-methyl-N-3-(4-pyridin-3-yl-pyrimidin-2-yl)-1,3-benzenediamine shown in formula (I) with 4-(4-methyl-piperazin-1-methyl)-benzoic ester shown in formula (II), under the action of a base and in a non-protonic organic solvent, in the above generic chemical structural formula, R represents aliphatic alkyl having 1-10 carbon, phenyl, substituted phenyl, benzyl or substituted benzyl. The present invention provides a new synthesis method of Imatinib, which is formed under mild reaction conditions, and is environmentally friendly with a high-yield.

Abstract: Substituted bicyclic heteroaryls having the general structure: and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity.

Abstract: Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110? activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lympho